BISMAS 2020
Conference Management System
Main Site
Submission Guide
Register
Login
User List | Statistics
Abstract List | Statistics
Paper List
Presentation Video
Online Q&A Forum
Access Mode
Ifory System
:: Question & Answer ::

Video Direct Link | Abstract

Abstract
ABS-263
What is the Profile of Quality of Life for Controlled Patients Taking Antiretrovirals? An Observation in Indonesia
Setiyo Budi Santoso (a*), Heni Lutfiyati (a), Ulfahishofi Hanifah Afifi (b), Shellyta Ratnafuri (b)
Corresponding Author: Setiyo Budi Santoso


Question & Answer to the Presentation

Question from Ms. Vanny Eka Septiana
2020.11.18 12:18:53

i am so interested with your presentation Mr. Setiyo Budi, and i want to ask why ARV therapy is done for at least 6 months ?
Thankyou
Replies:

Reply from Mr. Setiyo Budi Santoso
2020.11.18 13:30:43

This is the good question I^ve read to this forum.
Vani, you know that the subjects of my study are in a specific category, those who
are already receiving controlled antiretroviral therapy.

The key is ^controlled therapy^. this means that my subjects must have
guaranteed continuity in taking the drug.

I think six months is the minimum standard to guarantee that qualification.
Why six months, not three or nine months. Actually, you can argue with this.
However, six months is the time determined by the facilitator in the hospital to
evaluate the progress of therapy.

I hope my explanation is easy to understand.


Question from Ms. Yusi Dwi Nurcahyani
2020.11.18 12:12:45

What is the exact prevalence of HIV and AIDS in Indonesia according to the latest data.
How the magnitude of the problem in Indonesia is compared to other ASEAN countries
Replies:

Reply from Mr. Setiyo Budi Santoso
2020.11.18 13:47:35

Miss Yusi, i really like your attention.

First, we should use the data released by the national health ministry. That by
mid-2020, their number would reach 543,075 people.
See: https://www.kemkes.go.id/article/view/20092900003/kampanye-bulan-viral-
load-pentingnya-meng Tahu-status-pengobat-arv-pada-odha-melewat-
pemeriksa-.html

Further, my concern about this issue stems from the global fact (beyond of
ASEAN), that only 61.5% of them had accessed antiretroviral therapy. The
accessibility of antiretrovirals therapy in Indonesia was higher than the global data,
amounted to 69.8% from 349,822. However, it is only a-third population who
undergo controlled-therapy.
See: UNAIDS, ^Global HIV & AIDS Statistics - July 2018 Fact Sheet^, 2018

This is what then made me suspicious, and wanted to explore the affective things
behind people who routinely undergo therapy. The implication, this finding could
be a reference to empower those who are bored, or get off the path of adherence
to therapy.

I am happy to wait for your feedback


Question from Ms. Yusi Dwi Nurcahyani
2020.11.18 12:12:33

What is the exact prevalence of HIV and AIDS in Indonesia according to the latest data.
How the magnitude of the problem in Indonesia is compared to other ASEAN countries
Replies:


Question from Ms. Yusi Dwi Nurcahyani
2020.11.18 12:12:21

What is the exact prevalence of HIV and AIDS in Indonesia according to the latest data.
How the magnitude of the problem in Indonesia is compared to other ASEAN countries
Replies:


BISMAS 2020 - Conference Management System

Powered By Konfrenzi Ultimate 1.832L-Build7 © 2007-2025 All Rights Reserved